IDEXX Labs (NASDAQ: IDXX) reported Q1 EPS of $2.27, $0.01 better than the analyst estimate of $2.26. Revenue for the quarter came in at $837 million versus the consensus estimate of $839.72 million.

GUIDANCE:

IDEXX Labs sees FY2022 EPS of $8.11-$8.35, which includes items and may not compare to the consensus of $9.44.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.